Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
作者： T. Edholm , M. Degerblad , P. Grybäck , L. Hilsted , J. J. Holst
DOI: 10.1111/J.1365-2982.2010.01554.X
关键词:
摘要: … GLP-1 as the assay measures the sum of intact GLP-1 and its primary metabolite, GLP-1(9–36)amide, into which GLP-1 … to be an inhibition of antral motor activity 38 and relaxation of the …
sci-hub.se 参考文章(46)
J. B. Buse, R. R. Henry, J. Han, D. D. Kim, M. S. Fineman, A. D. Baron, , Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes Diabetes Care. ,vol. 27, pp. 2628- 2635 ,(2004) , 10.2337/DIACARE.27.11.2628
p. m. hellström, e. näslund, t. edholm, p. t. schmidt, j. kristensen, e. theodorsson, j. j. holst, s. efendic, GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterology and Motility. ,vol. 20, pp. 649- 659 ,(2008) , 10.1111/J.1365-2982.2007.01079.X
T Tolessa, M Gutniak, J J Holst, S Efendic, P M Hellström, Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. Journal of Clinical Investigation. ,vol. 102, pp. 764- 774 ,(1998) , 10.1172/JCI942
Mark Gutniak, Cathrine Ørkov, Jens J Holst, Bo Ahrén, Suad Efendić, None, Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. The New England Journal of Medicine. ,vol. 326, pp. 1316- 1322 ,(1992) , 10.1056/NEJM199205143262003
E Näslund, B Barkeling, N King, M Gutniak, JE Blundell, JJ Holst, S Rössner, PM Hellström, Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. International Journal of Obesity. ,vol. 23, pp. 304- 311 ,(1999) , 10.1038/SJ.IJO.0800818
C. Ørskov, A. Wettergren, J. J. Holst, Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day Scandinavian Journal of Gastroenterology. ,vol. 31, pp. 665- 670 ,(1996) , 10.3109/00365529609009147
Tesfaye Tolessa, Erik Näslund, Per M Hellström, The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway. Regulatory Peptides. ,vol. 98, pp. 33- 40 ,(2001) , 10.1016/S0167-0115(00)00220-2
P. R. Flatt, Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabetic Medicine. ,vol. 25, pp. 759- 764 ,(2008) , 10.1111/J.1464-5491.2008.02455.X
Tanya J. Little, Amelia N. Pilichiewicz, Antonietta Russo, Liza Phillips, Karen L. Jones, Michael A. Nauck, Judith Wishart, Michael Horowitz, Christine Feinle-Bisset, Effects of Intravenous Glucagon-Like Peptide-1 on Gastric Emptying and Intragastric Distribution in Healthy Subjects: Relationships with Postprandial Glycemic and Insulinemic Responses The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 1916- 1923 ,(2006) , 10.1210/JC.2005-2220
J. Dupre, S.A. Ross, D. Watson, J.C. Brown, STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN.1 The Journal of Clinical Endocrinology and Metabolism. ,vol. 37, pp. 826- 828 ,(1973) , 10.1210/JCEM-37-5-826